Literature DB >> 7718515

In vivo induction of CD4+ T cell responses by antigens covalently linked to synthetic microspheres does not require adjuvant.

C Gengoux1, C Leclerc.   

Abstract

Macrophages, dendritic cells or B lymphocytes have been shown to play a major role in the presentation of soluble antigens to CD4+ T cells. In contrast, the capacity of these cells to present particulate antigens such as bacterial or parasitic antigens to T cells remains controversial. To investigate this question, well defined particulate antigens were prepared by covalent linkage of proteins or peptides to 1 micron in diameter synthetic microspheres. The T cell immunogenicity of such particulate antigens was analyzed in vitro and in vivo. In vitro, a soluble protein such as hen egg lysozyme (HEL) coupled to beads stimulated a strong proliferative T cell response of lymph node cells from HEL-primed mice or of specific T cell hybridomas. HEL coupled to beads was presented to the specific T cell hybridomas by splenocytes or by peritoneal macrophages, but not by lymphoma B cells. Immunization of mice with several different protein antigens or with a synthetic peptide covalently linked to beads induced strong CD4+ T cell responses in the absence of adjuvant. The strong in vivo immunogenicity of proteins coupled to beads did not result from a non-specific adjuvant effect of beads since covalent linkage of the antigen to beads was strictly required to induce T cell responses in the absence of adjuvant. In vivo treatment by carrageenan showed that macrophages are required for the in vivo stimulation of T cell responses by these particulate antigens. Thus, these results demonstrated the role of phagocytic cells, especially macrophages, for in vivo presentation of particulate antigens. These particulate antigens represent an interesting approach for the development of new vaccines, and for the in vivo analysis of the role of various antigen presenting cells in T cell activation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7718515     DOI: 10.1093/intimm/7.1.45

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis.

Authors:  G Dadaglio; Z Moukrim; R Lo-Man; V Sheshko; P Sebo; C Leclerc
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy.

Authors:  Hans Grönlund; Susanne Vrtala; Ursula Wiedermann; Gerhard Dekan; Dietrich Kraft; Rudolf Valenta; Marianne Van Hage-Hamsten
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

3.  Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine.

Authors:  Chengji Cui; Vernon C Stevens; Steven P Schwendeman
Journal:  Vaccine       Date:  2006-08-17       Impact factor: 3.641

4.  Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.

Authors:  C Sedlik; M Saron; J Sarraseca; I Casal; C Leclerc
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii.

Authors:  S Corinti; D Medaglini; C Prezzi; A Cavani; G Pozzi; G Girolomoni
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

6.  Optimization of a murine immunization model for study of PF4/heparin antibodies.

Authors:  S Suvarna; R Qi; G M Arepally
Journal:  J Thromb Haemost       Date:  2009-02-24       Impact factor: 5.824

Review 7.  Nanovaccines: recent developments in vaccination.

Authors:  Tarala D Nandedkar
Journal:  J Biosci       Date:  2009-12       Impact factor: 2.795

8.  Generation of Tumor-Specific Cytotoxic T Cells From Blood via In Vitro Expansion Using Autologous Dendritic Cells Pulsed With Neoantigen-Coupled Microbeads.

Authors:  Adela Kiessling; Keerthana Ramanathan; Ola B Nilsson; Luigi Notari; Stefanie Renken; Rolf Kiessling; Hans Grönlund; Stina L Wickström
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

9.  Antigen presentation kinetics control T cell/dendritic cell interactions and follicular helper T cell generation in vivo.

Authors:  Robert A Benson; Megan K L MacLeod; Benjamin G Hale; Agapitos Patakas; Paul Garside; James M Brewer
Journal:  Elife       Date:  2015-08-10       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.